Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Global Biotech Company Chooses Soleo Health to Distribute Specialty Drug

By Soleo Health | November 7, 2018

Soleo Health, a provider of specialty infusion services, has been chosen by Shire, a global biotechnology company focused on rare diseases, as a provider of the specialty drug Vonvendi. [von Willebrand factor (Recombinant)]. 

Vonvendi is the first and only recombinant von Willebrand factor (rVWF or VWF), designed specifically for treating and managing adults with von Willebrand disease (VWD), the most common bleeding disorder today, which occurs when blood does not clot properly. VWD affects up to one percent of the world’s population[1], and many people are not accurately diagnosed.

VWD is caused by a deficiency or dysfunction of VWF, one of several types of proteins in the blood needed to facilitate proper blood clotting, resulting in impaired blood clotting, and it affects women and men equally.[2][3] Vonvendi works similarly to the body’s naturally occurring VWF, is administered intravenously to replace missing or dysfunctional VWF, and is indicated to treat and control of bleeding episodes and prevent excessive bleeding before and after surgery. Research shows that as many as 9 out of 10 people with VWD have not been diagnosed.[4]

Soleo Health was selected as a specialty drug distribution provider of vonvendi based on the company’s dedicated bleeding disorders program with deep clinical knowledge and broad expertise in treating and clinically managing those with bleeding disorders, including VWD. Soleo Health’s clinical and patient advocacy teams have undergone extensive training and education with respect to the dispensing, clinical management, and patient support for those receiving Vonvendi.
___________________________________________________________

References:

1. James PD, Goodeve AC. von Willebrand Disease. Genet Med. 2011;13(5):365-76. 

2. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171-232. 

3. Leebeek FW, Eikenboom JC. Von Willebrand’s Disease. N Engl J Med. 2016;375(21):2067-2080. 

4. What is von Willebrand disease (VWD)? World Federation of Hemophilia website. https://www.wfh.org/en/page.aspx?pid=673. Accessed May 3, 2017.

(Source: Soleo Health)

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE